Genetic risk and protective factors for the idiopathic inflammatory myopathies.
The idiopathic inflammatory myopathies, or myositis syndromes, are heterogeneous autoimmune diseases defined by chronic muscle inflammation of unknown cause. They likely develop after the interaction of genetic and environmental risk factors in the absence of protective factors. The known genetic risk and protective factors are common alleles at polymorphic immune response loci and vary depending on phenotype. Furthermore, genetic associations are stronger with phenotypes defined by clinical features and autoantibodies than with myositis patients as a whole. Genetic factors for myositis also vary by age of onset, ethnicity, and environmental exposure group. Of interest, risk genes for one phenotype are often protective for another, possibly explaining the mutual exclusivity of many myositis subgroups. International collaborations using genome-wide association studies are needed to identify additional genes, gene-gene, and gene-environment interactions, all of which have pathogenic, therapeutic, and preventative implications for these increasingly recognized disorders.
O'Hanlon
Terrance P
TP
National Institute of Environmental Health Sciences, National Institutes of Health, Room 1W101, Bethesda, MD 20892, USA. ohanlont@niehs.nih.gov
Miller
Frederick W
FW
D001741:Black or African American; D000367:Age Factors; D001323:Autoantibodies / Q000235:genetics*; D004781:Environmental Exposure; D020022:Genetic Predisposition to Disease / Q000208:ethnology / Q000235:genetics; D006680:HLA Antigens / Q000235:genetics*; D006801:Humans; D009220:Myositis / Q000208:ethnology / Q000235:genetics*; D012307:Risk Factors; D044465:White People
D001323:Autoantibodies; D006680:HLA Antigens
Rheumatology (Oxford). 2007 Dec;46(12):1786-91
18003662
Hum Immunol. 1999 Mar;60(3):255-8
10321963
J Autoimmun. 2006 Aug;27(1):62-8
16895750
J Rheumatol. 1998 May;25(5):1000-2
9598907
J Neurol Neurosurg Psychiatry. 2008 Sep;79(9):1056-60
18258695
Ann Neurol. 1990 Apr;27(4):343-56
2353792
Arthritis Rheum. 2008 Oct;58(10):3247-54
18821667
Arthritis Rheum. 2005 Sep;52(9):2607-15
16142757
J Rheumatol. 2004 Sep;31(9):1847-50
15338511
JAMA. 1993 Oct 20;270(15):1846-9
8411528
Arthritis Rheum. 2007 Nov;56(11):3784-92
17968926
Arthritis Rheum. 2000 Oct;43(10):2368-77
11037898
Ann Rheum Dis. 2009 Oct;68(10):1621-5
18930994
Hum Pathol. 1986 Jul;17(7):704-21
3459704
J Immunol. 1994 Mar 1;152(5):2569-76
8133064
Ann Rheum Dis. 2007 Jul;66(7):970-3
17405833
Curr Opin Rheumatol. 1997 Nov;9(6):520-6
9375281
Medicine (Baltimore). 2006 Mar;85(2):111-127
16609350
Arthritis Rheum. 2006 Nov;54(11):3682-9
17075819
J Invest Dermatol. 2002 Dec;119(6):1394-9
12485445
Arthritis Rheum. 2002 Jul;46(7):1885-93
12124873
Arthritis Rheum. 2006 Nov;54(11):3670-81
17075818
Rheumatology (Oxford). 2007 Sep;46(9):1411-6
17586554
Arthritis Rheum. 1983 Feb;26(2):214-6
6572047
Chin Med Sci J. 2002 Sep;17(3):198
12901547
Mol Med. 2007 Jan-Feb;13(1-2):59-68
17515957
J Autoimmune Dis. 2006 Feb 20;3:2
16504012
Clin Exp Immunol. 1995 Jun;100(3):519-28
7774065
Arthritis Rheum. 2004 Mar;50(3):1013-5
15022353
Arthritis Rheum. 2006 Dec;54(12):3979-87
17133612
Arthritis Rheum. 2008 Oct;58(10):3239-46
18821675
Annu Rev Immunol. 2008;26:29-55
18303998
J Rheumatol. 2004 Sep;31(9):1768-74
15338498
Arthritis Res Ther. 2006;8(1):R13
16507114
Arthritis Rheum. 1998 Apr;41(4):710-9
9550481
Arthritis Rheum. 2008 Dec;58(12):3941-50
19035492
Clin Exp Immunol. 2000 Jul;121(1):47-52
10886238
Medicine (Baltimore). 1991 Nov;70(6):360-74
1659647
Hum Immunol. 1995 Nov;44(3):131-5
8666549
Hum Immunol. 1981 Oct;3(2):181-6
6948801
Arthritis Rheum. 1999 Jun;42(6):1285-90
10366124
Hum Mol Genet. 2008 Oct 15;17(R2):R116-21
18852199
Medicine (Baltimore). 2005 Nov;84(6):338-349
16267409
Arthritis Rheum. 1996 Sep;39(9):1507-18
8814062